1. Home
  2. NBTX vs BYND Comparison

NBTX vs BYND Comparison

Compare NBTX & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • BYND
  • Stock Information
  • Founded
  • NBTX 2003
  • BYND 2009
  • Country
  • NBTX France
  • BYND United States
  • Employees
  • NBTX N/A
  • BYND N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • BYND Packaged Foods
  • Sector
  • NBTX Health Care
  • BYND Consumer Staples
  • Exchange
  • NBTX Nasdaq
  • BYND Nasdaq
  • Market Cap
  • NBTX 167.8M
  • BYND 194.0M
  • IPO Year
  • NBTX 2020
  • BYND 2019
  • Fundamental
  • Price
  • NBTX $4.10
  • BYND $2.93
  • Analyst Decision
  • NBTX Strong Buy
  • BYND Sell
  • Analyst Count
  • NBTX 1
  • BYND 3
  • Target Price
  • NBTX $8.00
  • BYND $4.00
  • AVG Volume (30 Days)
  • NBTX 11.5K
  • BYND 2.1M
  • Earning Date
  • NBTX 04-02-2025
  • BYND 05-07-2025
  • Dividend Yield
  • NBTX N/A
  • BYND N/A
  • EPS Growth
  • NBTX N/A
  • BYND N/A
  • EPS
  • NBTX N/A
  • BYND N/A
  • Revenue
  • NBTX N/A
  • BYND $319,580,000.00
  • Revenue This Year
  • NBTX N/A
  • BYND N/A
  • Revenue Next Year
  • NBTX $221.06
  • BYND $5.19
  • P/E Ratio
  • NBTX N/A
  • BYND N/A
  • Revenue Growth
  • NBTX N/A
  • BYND N/A
  • 52 Week Low
  • NBTX $2.76
  • BYND $2.23
  • 52 Week High
  • NBTX $7.29
  • BYND $9.24
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 64.63
  • BYND 56.38
  • Support Level
  • NBTX $3.64
  • BYND $2.79
  • Resistance Level
  • NBTX $4.20
  • BYND $3.17
  • Average True Range (ATR)
  • NBTX 0.16
  • BYND 0.19
  • MACD
  • NBTX 0.04
  • BYND 0.05
  • Stochastic Oscillator
  • NBTX 88.51
  • BYND 72.91

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: